返回
Rubella
DOI:10.1016/S0140-6736(14)60539-0.png)
摘要
En 中文
Rubella remains an important pathogen worldwide, with roughly 100 000 cases of congenital rubella syndrome estimated to occur every year. Rubella-containing vaccine is highly effective and safe and, as a result, endemic rubella transmission has been interrupted in the Americas since 2009. Incomplete rubella vaccination programmes result in continued disease transmission, as evidenced by recent large outbreaks in Japan and elsewhere. In this Seminar, we provide present results regarding rubella control, elimination, and eradication policies, and a brief review of new laboratory diagnostics. Additionally, we provide novel information about rubella-containing vaccine immunogenetics and review the emerging evidence of interindividual variability in humoral and cell-mediated innate and adaptive immune responses to rubella-containing vaccine and their association with haplotypes and single-nucleotide polymorphisms across the human genome.
Keyword:
IMMUNE-RESPONSE
T-CELL
CYTOKINE RESPONSES
FUCHS UVEITIS
SYNDROME CRS
ORAL FLUID
PCR ASSAY
VIRUS
MEASLES
VACCINE
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
88.5
论文数:
5.4W
被引数:
34.8W
机构
引用论文
Predominant inflammatory cytokine secretion pattern in response to two doses of live rubella vaccine in healthy vaccinees
CYTOKINE
IF3.7

